- M. Myeloma and Chronic Myeloid Leukemia
- Preclinical research has a focus on cell therapy
- Professor on medical education
After Medical School and a PhD program on immunology (both at the medical school in Maastricht) Gerard Bos started training in internal medicine in Maastricht for two years. He moved to The Hague to a non-university Hospital to obtain clinical experience outside the university system. After training for internal medicine he was trained as a Haematologist again in University and non-University hospitals. After registration as a haematologist (1995) he stayed in the Daniel den Hoed Cancer Centre for three years as clinical fellow, especially to obtain more clinical experience. Thereafter he obtained a fellowship (Clinical Research Award by the Dutch Cancer Foundation) to perform a two year research program on tumor-immunology (Leiden, Brussels and Utrecht). He started in Maastricht 2000, as internist-haematologist.
His extra focus is on M. Myeloma and Chronic Myeloid Leukemia. Preclinical research has a focus on cell therapy: development of cancer vaccines, the role of natural killer cells in the fight against cancer, early detection of breast cancer and immune reconstitution after bone marrow transplantation. In 2013 he was appointed as professor on medical education and tumor-immunology.